Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „causality“
Suchtreffer
Begriffe & Kennungen
Alimta · 4.8 · 8 Table 4. Frequencies of all grades adverse drug events regardless of causality from the pivotal registration
Eintrag öffnenAlimta · 4.8 · The table 4 lists the adverse drug events regardless of causality associated with pemetrexed used either as a
Eintrag öffnenEcalta · 4.8 · The following table includes, the all-causality adverse reactions (MedDRA terms) from 840 subjects receiving 1
Eintrag öffnenEptifibatide Accord · 4.8 · Note that causality has not been determined for all adverse reactions.
Eintrag öffnenEptifibatide Accord · 4.8 · Note that causality has not been determined for all adverse reactions.
Eintrag öffnenEvoltra · 4.8 · Patients with advanced stages of ALL or AML may have confounding medical conditions that make causality of adv
Eintrag öffnenFarydak · 4.8 · Discontinuation due to adverse events, regardless of causality, was observed in 36.2% of patients. The most co
Eintrag öffnenIsentress · 4.8 · In clinical studies of treatment-experienced patients, rash, irrespective of causality, was more commonly obse
Eintrag öffnenIsentress · 4.8 · In clinical studies of treatment-experienced patients, rash, irrespective of causality, was more commonly obse
Eintrag öffnenIsentress · 4.8 · In clinical studies of treatment-experienced patients, rash, irrespective of causality, was more commonly obse
Eintrag öffnenIsentress · 4.8 · In clinical studies of treatment-experienced patients, rash, irrespective of causality, was more commonly obse
Eintrag öffnenJakavi · 4.8 · 44 Discontinuation due to adverse events, regardless of causality, was observed in 29.4% of patients in REACH2
Eintrag öffnenJakavi · 4.8 · Discontinuation due to adverse events, regardless of causality, was observed in 18.1% of patients in REACH3 an
Eintrag öffnenJakavi · 4.8 · Discontinuation due to adverse events, regardless of causality, was observed in 18.1% of patients in REACH3 an
Eintrag öffnenJakavi · 4.8 · Discontinuation due to adverse events, regardless of causality, was observed in 19.4% of patients.
Eintrag öffnenJakavi · 4.8 · Discontinuation due to adverse events, regardless of causality, was observed in 29.4% of patients in REACH2 an
Eintrag öffnenJakavi · 4.8 · Discontinuation due to adverse events, regardless of causality, was observed in 30.0% of patients.
Eintrag öffnenKausalität
Eintrag öffnenKisqali · 4.8 · Dose reduction due to adverse events, regardless of causality, occurred in 22.8% of patients receiving Kisqali
Eintrag öffnenKisqali · 4.8 · Dose reduction due to adverse events, regardless of causality, occurred in 39.5% of patients receiving Kisqali
Eintrag öffnen